ALPS ADVISORS INC - Q2 2021 holdings

$11.3 Billion is the total value of ALPS ADVISORS INC's 996 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .

 Value Shares↓ Weighting
NEU ExitNEWMARKET CORP$0-564
-100.0%
-0.00%
APRE ExitAPREA THERAPEUTICS INC$0-38,329
-100.0%
-0.00%
EGOV ExitNIC INC$0-10,020
-100.0%
-0.00%
VYGR ExitVOYAGER THERAPEUTICS INC$0-67,782
-100.0%
-0.00%
TARA ExitPROTARA THERAPEUTICS INC$0-20,279
-100.0%
-0.00%
ASMB ExitASSEMBLY BIOSCIENCES INC$0-59,743
-100.0%
-0.00%
APTX ExitAPTINYX INC$0-114,443
-100.0%
-0.00%
CLGX ExitCORELOGIC INC$0-4,282
-100.0%
-0.00%
HMSY ExitHMS HLDGS CORP$0-8,144
-100.0%
-0.00%
CNCE ExitCONCERT PHARMACEUTICALS INC$0-55,449
-100.0%
-0.00%
NCNA ExitNUCANA PLCsponsored adr$0-92,577
-100.0%
-0.01%
KMDA ExitKAMADA LTD$0-80,943
-100.0%
-0.01%
PRQR ExitPROQR THRAPEUTICS N V$0-90,714
-100.0%
-0.01%
AVRO ExitAVROBIO INC$0-74,994
-100.0%
-0.01%
EGRX ExitEAGLE PHARMACEUTICALS INC$0-23,570
-100.0%
-0.01%
CVM ExitCEL-SCI CORP$0-69,878
-100.0%
-0.01%
VXRT ExitVAXART INC$0-198,053
-100.0%
-0.01%
CFX ExitCOLFAX CORP$0-31,400
-100.0%
-0.01%
ARCC ExitARES CAPITAL CORP$0-72,000
-100.0%
-0.01%
ZIOP ExitZIOPHARM ONCOLOGY INC$0-388,379
-100.0%
-0.01%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-71,581
-100.0%
-0.01%
GSS ExitGOLDEN STAR RES LTD CDA$0-511,181
-100.0%
-0.02%
QURE ExitUNIQURE NV$0-81,401
-100.0%
-0.03%
IRWD ExitIRONWOOD PHARMACEUTICALS INC$0-291,213
-100.0%
-0.03%
IAC ExitIAC INTERACTIVECORP NEW$0-27,630
-100.0%
-0.06%
INSM ExitINSMED INC$0-186,428
-100.0%
-0.06%
FATE ExitFATE THERAPEUTICS INC$0-130,688
-100.0%
-0.10%
BBJP ExitJ P MORGAN EXCHANGE-TRADED Fbetbuld japan$0-581,124
-100.0%
-0.16%
XRX ExitXEROX HOLDINGS CORP$0-859,160
-100.0%
-0.20%
STX ExitSEAGATE TECHNOLOGY PLC$0-301,116
-100.0%
-0.23%
NBLX ExitNOBLE MIDSTREAM PARTNERS LP$0-4,515,431
-100.0%
-0.64%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Red Rocks Capital LLC #1
  • Morningstar Investment Management LLC #2
  • Rocky Mountain Advisers, LLC #3
  • RiverFront Investment Group, LLC #4
  • Sprott Asset Management LP #5
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENTERPRISE PRODUCTS PARTNERS L42Q3 20238.6%
PLAINS ALL AMER PIPELINE LP42Q3 20238.5%
NuStar LP MLP42Q3 20232.9%
Genesis Energy MLP42Q3 20232.7%
Vgrd Total Bond Mkt ETF42Q3 20231.4%
Vgrd MSCI EAFE ETF42Q3 20231.0%
PFIZER INC42Q3 20230.8%
VERIZON COMMUNICATIONS INC42Q3 20230.6%
Vgrd FTSE Emerge Mkt ETF42Q3 20230.5%
AT&T INC42Q3 20230.4%

View ALPS ADVISORS INC's complete holdings history.

Latest significant ownerships (13-D/G)
ALPS ADVISORS INC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Crestwood Equity Partners LPFebruary 13, 202312,335,02711.8%
DCP Midstream, LPFebruary 13, 202313,458,5116.5%
HOLLY ENERGY PARTNERS LPFebruary 13, 20236,821,8625.4%
Magellan Midstream Partners, L.P.February 13, 202313,179,3306.4%
EnLink Midstream, LLCFebruary 09, 202133,136,6696.0%
NGL Energy Partners LPFebruary 09, 202125,376,95511.7%
TC PIPELINES LPFebruary 09, 20216,072,7408.5%
Western Midstream Operating, LPFebruary 09, 202124,153,6296.1%
EnLink Midstream, LLCFebruary 07, 202031,194,7146.3%
Shell Midstream Partners, L.P.February 07, 202014,825,7546.4%

View ALPS ADVISORS INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G2024-02-05
SC 13G2024-02-05
SC 13G2024-02-05
SC 13G2024-02-05

View ALPS ADVISORS INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (11307102000.0 != 11307105000.0)

Export ALPS ADVISORS INC's holdings